Differential expression of genes and differentially perturbed pathways associated with very high evening fatigue in oncology patients receiving chemotherapy

Authors:

Abstract
Fatigue is the most common symptom associated with cancer and its treatment. Investigation of molecular mechanisms associated with fatigue in oncology patients may identify new therapeutic targets. The objectives of this study were to evaluate the relationships between gene expression and perturbations in biological pathways and evening fatigue severity in oncology patients who received chemotherapy (CTX).
Funding Information
  • National Cancer Institute (R01CA134900, K05CA168960)
  • National Center for Advancing Translational Sciences (KL2TR000143)
  • National Institute of Nursing Research (T32NR008346)

This publication has 46 references indexed in Scilit: